Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
25.7% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
25.2% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.1% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
10
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CYD
China Yuchai International
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Expanding Overseas Manufacturing Will Unlock Emerging Market Demand
Key Takeaways Rapid market share gains, global expansion, and profitable joint ventures could drive revenue and earnings growth well above industry expectations. Leadership in alternative powertrain technologies and advanced cost controls position the company for rising margins and resilience amid industry shifts.
View narrative
US$21.82
FV
30.2% overvalued
intrinsic discount
9.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Avantor
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Pharma Contracts And R&D Will Drive Growth Amid Price Pressures
Key Takeaways Strong demand from pharma and biotech, coupled with innovation and digital transformation, positions Avantor for sustained revenue and customer growth. Cost transformation and investment in specialized solutions are set to drive margin improvement and capitalize on higher-value market segments.
View narrative
US$14.12
FV
10.3% undervalued
intrinsic discount
2.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
7 days ago
author updated this narrative
Federated Hermes
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Digital Asset Infrastructure And ESG Trends Will Transform Markets
Key Takeaways Expansion in digital assets, alternative investments, and ESG offerings is expected to diversify revenue streams and broaden the client base. Demographic trends and demand for safety and yield position the firm for sustained growth in money markets and fixed income products.
View narrative
US$48.14
FV
8.4% overvalued
intrinsic discount
3.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
6 days ago
author updated this narrative
Bapcor
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Simplified Operations And E-commerce Upgrades Will Drive Success
Key Takeaways Operational streamlining, customer focus, and business integration are set to sustain growth, enhancing both net margins and earnings. Technology investment and network expansion in Trade are projected to boost revenue through improved efficiency and market presence.
View narrative
AU$4.23
FV
7.1% undervalued
intrinsic discount
0.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
5 days ago
author updated this narrative
Acutaas Chemicals
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
CDMO Prospects Will Strengthen With New Ankleshwar Site And Semiconductor Expansion
Key Takeaways Strategic developments in CDMO and semiconductor segments are set to drive significant revenue growth through innovative technology and market expansion. Operational efficiencies and a strong focus on advanced pharmaceutical intermediates are enhancing margins and sustaining long-term earnings growth.
View narrative
₹1.47k
FV
10.2% undervalued
intrinsic discount
32.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
11 days ago
author updated this narrative
Stabilus
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Industrial Automation And Machinery Investments Will Drive Recovery
Key Takeaways Strategic cost-cutting and automation investments are set to significantly expand margins and earnings as market demand rebounds. Successful refinancing, acquisitions, and innovation position the company strongly for global growth in automation and motion control markets.
View narrative
€36.29
FV
35.1% undervalued
intrinsic discount
3.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 days ago
author updated this narrative
Northern Technologies International
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Global Expansion And Compostable Plastics Demand Will Shape Future Success
Key Takeaways Expansion in Southeast Asia and the Middle East is set to boost oil and gas sales, impacting overall revenue positively in the near future. Growth in Natur-Tec through new customer acquisitions and product innovation indicates promising sales and margin enhancements.
View narrative
US$13.00
FV
41.2% undervalued
intrinsic discount
3.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
14 days ago
author updated this narrative
Mirum Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Genetic Testing And International Expansion Will Broaden Rare Disease Markets
Key Takeaways Broader patient identification, international expansion, and supportive reimbursement environments are driving sustained revenue growth and improving margins for Mirum's portfolio. Advancing late-stage pipeline programs and leveraging precision medicine support future product expansion, revenue diversification, and long-term earnings acceleration.
View narrative
US$77.20
FV
16.2% undervalued
intrinsic discount
22.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
Updated
narrative
Patrick Industries
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Rising Outdoor Recreation And Marine Demand Will Drive Enduring Opportunities
Key Takeaways Product innovation, automation, and aftermarket growth drive higher margins, operational efficiency, and stable revenues across more diversified end markets. Strategic acquisitions and vertical integration are strengthening market share, expanding content per unit, and enhancing long-term earnings potential.
View narrative
US$108.00
FV
0.3% overvalued
intrinsic discount
3.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
6 days ago
author updated this narrative
Value any company in seconds
Popular companies